Manual práctico de Trombosis y Hemostasia de la SETH

— 1 4 8 — I I . PA T O LO G Í A D E L A H E M O ST A S I A 3. Gould MK, García DA,Wren SM, Karanicolas PJ,Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients: Anti- thromboticTherapy and Prevention ofThrombosis, 9 th ed:Ameri- can College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(Suppl 2):e227S-e277S. 4. Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, et al. Prevention of VTE in nonsurgical patients: Antithrombotic The- rapy and Prevention of Thrombosis, 9 th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(Suppl 2):e195S-e226S. 5. Kearon C. Diagnosis of suspected venous thromboembo- lism. Hematology Am Soc Hematol Educ Program 2016;2016:397-403. 6. Takach Lapner S, Julian JA, Linkins LA, Bates SM, Kearon C. Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies. J Thromb Haemost 2016;14:1953-9. 7. Linnemann B,Bauersachs R,Rott H,Halimeh S,Zotz R,Gerhardt A, et al.; Working Group in Women’s Health of the Society of Thrombosis and Haemostasis. Diagnosis of pregnancy-associated venous thromboembolism-position paper of theWorking Group inWomen’s Health of the Society of Thrombosis and Haemosta- sis (GTH).Vasa 2016;45:87-101. 8. Klok FA, Huisman MV. Management of incidental pulmonary em- bolism. Eur Respir J 2017;49(6). pii: 1700275. 9. Kearon C,Akl EA, Ornelas J, Blaivas A, Jiménez D, Bounameaux H, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016;149:315-52. 10. Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Wes- tendorf J, et al.; PEITHO Investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014;370:1402-11. 11. Muriel A, Jiménez D, Aujesky D, Bertoletti L, Decousus H, Lapor- te S, et al.; RIETE Investigators. Survival effects of inferior vena cava filter in patients with acute symptomatic venous throm- boembolism and a significant bleeding risk. J Am Coll Cardiol 2014;63:1675-83. 12. Jiménez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, et al.; RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptoma- tic pulmonary embolism.Arch Intern Med 2010;170:1383-9. 13. Debourdeau P, Farge D, Beckers M, Baglin C, Bauersachs RM, Brenner B, et al. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with cen- tral venous catheters in patients with cancer. J Thromb Haemost 2013;11:71-80. 14. Gómez-Outes A, Lecumberri R, Suárez-Gea ML, Terleira- Fernández AI, Monreal M,Vargas-Castrillón E. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Re- ceiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review. J Cardiovasc Pharmacol Ther 2015;20:490-500. 15. Kahn SR, Galanaud JP, Vedantham S, Ginsberg JS. Guidance for the prevention and treatment of the post-thrombotic syndrome. J Thromb Thrombolysis 2016;41:144-53. 16. Piazza G, Goldhaber SZ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2011;364:351-60.